Last reviewed · How we verify

Quadratus Lumborum (QL) Block

George Washington University · FDA-approved active Small molecule

A QL block is a regional anesthesia technique that delivers local anesthetic to the quadratus lumborum muscle plane to block pain signals from the lower abdomen and flank.

A QL block is a regional anesthesia technique that delivers local anesthetic to the quadratus lumborum muscle plane to block pain signals from the lower abdomen and flank. Used for Perioperative analgesia for abdominal and flank surgery, Postoperative pain management for lower abdominal procedures.

At a glance

Generic nameQuadratus Lumborum (QL) Block
SponsorGeorge Washington University
ModalitySmall molecule
Therapeutic areaAnesthesia/Pain Management
PhaseFDA-approved

Mechanism of action

The quadratus lumborum block targets the thoracolumbar fascia and muscle plane, anesthetizing branches of the spinal nerves that supply the lower abdominal wall, flank, and lower back. This regional anesthesia approach provides perioperative pain relief and reduces the need for systemic opioids. It is a procedural intervention rather than a pharmaceutical drug.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: